Literature DB >> 7536019

Colorimetric assay for rapid screening of corticotropin releasing factor receptor ligands.

C W Liaw1, D E Grigoriadis, E B De Souza, T Oltersdorf.   

Abstract

The corticotropin releasing factor (CRF) receptor is known to be coupled to Gs and transduces its signal through stimulation of cyclic AMP (cAMP) production. Here we describe the characterization of several stable CRF receptor-expressing LVIP2.0Zc cell lines that also contain an exogenous cAMP-responsive beta-galactosidase reporter gene construct. The CRF receptor activity was assayed by measuring the induction of beta-galactosidase in response to CRF. Rat/human and bovine CRF stimulated beta-galactosidase activity in a dose-dependent manner with EC50 values of approximately 0.1 nM; the biologically weak deamidated analog of bovine CRF was approximately 500-fold less potent. The CRF receptor antagonist, [d-Phe12,Nle21,38,Ala32]r/hCRF(12-41) produced a dose-dependent inhibition of CRF-stimulated beta-galactosidase activity, further demonstrating the pharmacological specificity of the interaction. The magnitude of the maximal response to CRF varied among individual cell lines. This variation was independent of the level of CRF receptor expression, but reflected differences in the intrinsic activity of adenylate cyclase. In contrast to most cAMP assay systems, the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine decreased the CRF-induced beta-galactosidase activity when used in the context of the assay regimen described here. Since the assay can be easily performed in a high-throughput 96-well plate format, these cell lines provide an efficient way for the identification of CRF receptor agonists and antagonists.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7536019     DOI: 10.1007/BF02736750

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  24 in total

Review 1.  Physiology and pharmacology of corticotropin-releasing factor.

Authors:  M J Owens; C B Nemeroff
Journal:  Pharmacol Rev       Date:  1991-12       Impact factor: 25.468

2.  Expression cloning of a human corticotropin-releasing-factor receptor.

Authors:  R Chen; K A Lewis; M H Perrin; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

3.  Corticotropin releasing factor receptor-mediated stimulation of adenylate cyclase activity in the rat brain.

Authors:  F M Chen; L M Bilezikjian; M H Perrin; J Rivier; W Vale
Journal:  Brain Res       Date:  1986-08-27       Impact factor: 3.252

4.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

5.  Corticotropin-releasing factor stimulants adenylate cyclase activity in the anterior pituitary gland.

Authors:  F Labrie; B Gagné; G Lefèvre
Journal:  Life Sci       Date:  1982-09-13       Impact factor: 5.037

6.  CRF stimulates adenylate cyclase activity in the intermediate lobe of the pituitary gland.

Authors:  F Labrie; B Gagné; G Lefèvre; H Meunier
Journal:  Mol Cell Endocrinol       Date:  1983-06       Impact factor: 4.102

7.  Functional corticotropin-releasing factor (CRF) receptors in mouse spleen: evidence from adenylate cyclase studies.

Authors:  E L Webster; G Battaglia; E B De Souza
Journal:  Peptides       Date:  1989 Mar-Apr       Impact factor: 3.750

8.  Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo.

Authors:  K Karalis; H Sano; J Redwine; S Listwak; R L Wilder; G P Chrousos
Journal:  Science       Date:  1991-10-18       Impact factor: 47.728

9.  Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2.

Authors:  V K Singh; S J Leu
Journal:  Neurosci Lett       Date:  1990-12-11       Impact factor: 3.046

10.  Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis.

Authors:  L J Crofford; H Sano; K Karalis; E L Webster; E A Goldmuntz; G P Chrousos; R L Wilder
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.